Clicky

Lixte Biotechnology Holdings, Inc.(LIXT) News

Date Title
Aug 15 LIXTE Biotechnology Holdings to Present at Two Investor Conferences
Aug 15 Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event
Jun 14 LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial
Jun 14 LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial
May 20 LIXTE Biotechnology Holdings Provides Update on Recent Activities
Jul 18 LIXTE Biotechnology Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules
Jul 17 Preclinical Results of LIXTE Biotechnology’s Collaboration with Netherlands Cancer Institute Reveal Novel Mechanism by which LIXTE’s Lead Clinical Compound LB-100 Enhances Effectiveness of Immunotherapy and Chemotherapy